MENU
CSCIF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

COSCIENS Biopharma (CSCIF) Ownership - Who owns COSCIENS Biopharma?

Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
6.7M
P/E Ratio
N/A
Total Cash
8.52M
Projected Growth
N/A
Total Debt
2.17M
Revenue
9.05M
Risk (Beta)
-0.24
Dividend Yield
N/A
Total Cash/Share
2.68
Total Debt/Equity
N/A
Revenue/Share
2.87 USD as % of share price

Fundamentals

CSCIF
Capitalization
6.7M
P/E Ratio
N/A
Risk (Beta)
-0.24
Dividend Yield
N/A
Total Cash
8.52M
Total Cash/Share
2.68
Total Debt
2.17M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.87%
Revenue
9.05M
ROE
N/A
Book Value
5.08M
P/B Ratio
1.35
Cash Flow
N/A
Earnings
-4.94
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
22.6M
Current Ratio
3.47
Current Revenue Per Employee
37075.00
Dividends Per Share - Security
N/A
EBITDA
-12.37M
Float
N/A
Float - Current
N/A
Gross Income Margin
41.87
Revenue To Assets
-44.08
Shares Held By Institutions
10.6K
Shares Outstanding - Current
3.18M
Total Liabilities
18.8M
Total Volume MTD
N/A
Value
1
Gain YTD
4.369
View a ticker or compare two or three
CSCIF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details